The Food and Drug Administration recently issued a warning on the use of SSRIs with regard to children, adolescents, and young adults with depression. This message warned of an increased risk for

A) suicidal ideation.
B) attention-deficit disorder.
C) eating disorders.
D) sleep disorders.

A